Traws Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer in the United States. The company is headquartered in Newtown, Pennsylvania. Show more

12 PENNS TRAIL, NEWTOWN, PA, UNITED STATES, 18940, Newtown, PA, 18940, USA

https://www.trawspharma.com

BIOTECHNOLOGY

HEALTHCARE

Start AI Chat

Market Cap

8.145M

52 Wk Range

$0.43 - $3.27

Previous Close

$0.52

Open

$0.52

Volume

219,733

Day Range

$0.52 - $0.54

Enterprise Value

3.178M

Cash

3.133M

Avg Qtr Burn

-2.576M

Insider Ownership

5.33%

Institutional Own.

40.06%

Qtr Updated

03/31/26

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Rigosertib + Pembrolizumab Details Melanoma, Skin cancer, Cancer	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Rigosertib Details Cutaneous squamous cell carcinoma, Cancer, Solid tumor/s	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Ratutrelvir (TRX01) Details COVID-19	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
TRX100 (tivoxavir marboxil) Details Influenza, Viral infection	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Narazaciclib + letrozole Details Cancer, Solid tumor/s, Endometrial cancer	Phase 1/2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Rigosertib + Nivolumab Details Cancer, Non-small cell lung carcinoma	Phase 1/2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Narazaciclib (ON 123300) Details Solid tumor/s, Cancer, Breast cancer, ER+/HER2- breast cancer, Metastatic breast cancer	Phase 1/2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.